A 5-year-old girl with failure to thrive and multiorgan disease was referred to our center for chronic hypoxemia. On evaluation, we noted tachypnea (respiratory rate 35/min), supraclavicular retractions, median diurnal oxygen saturation as measured by pulse oximetry (Sp O 2 ) = 91.7% at rest, percentage of time below Sp O 2 90% at 26% during sleep, and clubbing. A computed tomography scan showed diffuse interstitial lung disease (Figure 1 ). Spirometry was normal (TLC, 83% of predicted; FEV 1 , 83% of predicted; FEV 1 /FVC, 98%; and forced expiratory flow, midexpiratory phase, 142% of predicted), but it was not possible to measure DL CO . BAL analysis found hypercellularity (490 3 10 3 cells/ml), lymphocytosis (69% lymphocytes), and a negative microbiological evaluation. Transbronchial lung biopsies were inconclusive.
The patient's medical history included intrauterine growth restriction, severe growth failure (24 SD), lymphocytic enteropathy with total villous atrophy, pseudoceliac disease, hepatosplenomegaly, dental abnormalities, and atopic dermatitis. After the progression of lung disease, she subsequently developed bilateral knee oligoarthritis and worsening enteropathy, requiring parenteral nutrition. Further extrapulmonary evaluation showed massive hyper-IgA, B-lymphocyte deficiency, renal disease with tubulopathy, central corticotropic insufficiency, and lymphocytic sialadenitis.
Given the complexity of the patient's multiorgan autoimmune disease, whole-exome sequencing was performed showing a heterozygous germline gain-of-function (GOF) STAT3 (signal transducer and activator of transcription 3) mutation (E415L). Segregation of the mutation and Sanger verification confirmed a de novo mutation. Luciferase reporter assay, performed as previously described (1), confirmed GOF activity (data not shown). STAT3 GOF, described recently, results in early-onset growth failure, multiorgan autoimmunity, immunodeficiency, and lymphoproliferation. To date, 28 cases have been reported; among these, 7 presented with interstitial pneumonitis (1) (2) (3) (4) , of which 4 were consistent with lymphoid interstitial pneumonia. In addition, several publications have suggested that aberrant STAT3 signaling plays a critical role in the pathogenesis of interstitial and fibrotic lung disease (5) .
STAT3 GOF is an important new clinical entity to consider in childhood interstitial lung disease associated with hematological and multiorgan autoimmune disease. n 
